Literature DB >> 21036245

Constitutively active μ-opioid receptors.

Mark Connor1, John Traynor.   

Abstract

The μ-opioid receptor is the G protein coupled receptor (GPCR) responsible for the analgesic, rewarding and unwanted effects of morphine and similar drugs. Constitutive activity of GPCRs is a phenomenon that likely reflects receptors spontaneous adopting conformations that can activate G proteins, and is likely to be common to most if not all GPCRs. Basal constitutive activity has been observed in some systems with μ-opioid receptors, and constitutive activity is expressed by mutant μ-opioid receptors with amino acid substitutions in regions known to be important for signaling. However, μ-opioid receptors are unique in that a putative constitutively active state of the receptor, the μ*-state, has been suggested to be induced by prolonged agonist treatment. The μ*-state is thought to contribute to processes underlying adaptation to and withdrawal from opioid treatment, and may have a ligand sensitivity distinct from basal constitutive activity of the μ-opioid receptor or that exhibited by μ-opioid receptor mutants. In this chapter, we outline methods for measuring constitutively active μ-opioid receptors, including some that take advantage of the fairly direct coupling of the receptor to ion channels. We also briefly summarize the pharmacology of the different constitutively active μ-opioid receptor states, and highlight the areas where we need to know more. We hope that a better understanding of constitutive activity at the μ-opioid receptor may provide information useful in developing ligands that access subsets of receptor conformations, offering the potential to fine-tune opioid pharmacotherapy.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036245     DOI: 10.1016/B978-0-12-381298-8.00022-8

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  15 in total

1.  Reply to Wang and Sadée.

Authors:  Graeme Henderson; Edward T Bullmore
Journal:  Psychopharmacology (Berl)       Date:  2015-03-11       Impact factor: 4.530

Review 2.  Opioids and Chronic Pain: Where Is the Balance?

Authors:  Mellar P Davis; Zankhana Mehta
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

3.  Mechanisms of μ-opioid receptor inhibition of NMDA receptor-induced substance P release in the rat spinal cord.

Authors:  Wenling Chen; Helena S Ennes; James A McRoberts; Juan Carlos Marvizón
Journal:  Neuropharmacology       Date:  2017-10-16       Impact factor: 5.250

4.  Constitutive Desensitization of Opioid Receptors in Peripheral Sensory Neurons.

Authors:  Laura C Sullivan; Teresa S Chavera; Raehannah J Jamshidi; Kelly A Berg; William P Clarke
Journal:  J Pharmacol Exp Ther       Date:  2016-09-22       Impact factor: 4.030

Review 5.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

6.  Caged naloxone reveals opioid signaling deactivation kinetics.

Authors:  Matthew R Banghart; John T Williams; Ruchir C Shah; Luke D Lavis; Bernardo L Sabatini
Journal:  Mol Pharmacol       Date:  2013-08-19       Impact factor: 4.436

Review 7.  Regulation and Functional Implications of Opioid Receptor Splicing in Opioid Pharmacology and HIV Pathogenesis.

Authors:  Patrick M Regan; Dianne Langford; Kamel Khalili
Journal:  J Cell Physiol       Date:  2015-11-24       Impact factor: 6.384

8.  Endogenous analgesia, dependence, and latent pain sensitization.

Authors:  Bradley K Taylor; Gregory Corder
Journal:  Curr Top Behav Neurosci       Date:  2014

9.  Sustained Suppression of Hyperalgesia during Latent Sensitization by μ-, δ-, and κ-opioid receptors and α2A Adrenergic Receptors: Role of Constitutive Activity.

Authors:  Wendy M Walwyn; Wenling Chen; Hyeyoung Kim; Ani Minasyan; Helena S Ennes; James A McRoberts; Juan Carlos G Marvizón
Journal:  J Neurosci       Date:  2016-01-06       Impact factor: 6.167

10.  GRK2 Dictates a Functional Switch of the Peripheral Mu-Opioid Receptor.

Authors:  Yan Zhang; Nathaniel A Jeske
Journal:  ACS Chem Neurosci       Date:  2020-11-11       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.